tegafur has been researched along with Signet Ring Cell Carcinoma in 53 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe our experience with a patient who had undifferentiated gastric carcinoma with extensive lymph node metastasis, including para-aortic lymph-node metastasis, and had a complete response to induction therapy with methotrexate plus 5-fluorouracil (sequential therapy with MTX, 5-FU, and Leucovorin) and secondary treatment with oral TS-1." | 3.73 | [Stage IV gastric cancer patient who underwent palliative gastrectomy showing complete response to induction therapy with methotrexate plus 5-fluorouracil and secondary treatment with oral TS-1]. ( Hiramatsu, K; Mizukami, Y; Momiyama, M; Nagashima, T; Niimi, K; Suzuki, M, 2005) |
| "Patients with potentially resectable gastric cancer were eligible." | 2.90 | Phase II trial of neoadjuvant chemotherapy with intraperitoneal paclitaxel, S-1, and intravenous cisplatin and paclitaxel for stage IIIA or IIIB gastric cancer. ( Chiba, Y; Imano, M; Iwama, M; Kimura, Y; Nishida, S; Shinkai, M; Shiraisi, O; Tsubaki, M; Yasuda, A; Yasuda, T, 2019) |
| "Ovarian cancer was suspected, and total abdominal hysterectomy, bilateral salpingo-oophorectomy, and omentectomy were performed." | 1.56 | A case of primary ovarian signet-ring cell carcinoma treated with S-1/CDDP therapy. ( Aida, T; Baba, T; Saito, T; Sasou, S; Shoji, T; Takeshita, R, 2020) |
| "The study included 405 gastric cancer patients who underwent curative gastrectomy with D2 lymph node dissection and received adjuvant therapy between January 2008 and July 2009." | 1.40 | Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study. ( Bae, JM; Choi, MG; Kang, WK; Kim, S; Lee, J; Lee, JH; Lee, SJ; Lim, DH; Lim, HY; Park, JO; Park, SH; Park, YS; Sohn, TS, 2014) |
| "Detecting aortic thrombosis is important because it is a fatal condition." | 1.39 | Acute aortic thrombosis during cisplatin based chemotherapy for gastric cancer. ( Ito, S; Nakamura, Y; Noumi, T; Sasaki, Y, 2013) |
| "A 35-year-old female with scirrhous stomach cancer (stage IV) was treated with a combination of 5-aminolevulinic acid (ALA), sodium dichloroacetate (DCA), hyperthermotherapy, and immunotherapy as terminal care." | 1.39 | A patient with scirrhous stomach cancer treated with combination of hyperthermotherapy and 5-aminolevulinic acid (ALA). ( Goto, S; Kamigaki, T; Saito, M; Yano, K, 2013) |
| "Colorectal cancer associated with Crohn's disease (CD) is increasing in proportion to the number of patients with CD in Japan." | 1.39 | Metachronous, colitis-associated rectal cancer that developed after sporadic adenocarcinoma in an adenoma in a patient with longstanding Crohn's disease: a case report. ( Doki, Y; Haraguchi, N; Hata, T; Mizushima, T; Mori, M; Nakajima, K; Nishimura, J; Takemasa, I; Takeyama, H; Uemura, M; Yamamoto, H, 2013) |
| "The final diagnosis was stage II gastric cancer, designated T1N2M0 according to the Japanese classification of gastric carcinoma." | 1.38 | Intramucosal gastric cancer with fifteen metastatic lymph nodes: report of a case. ( Bando, E; Kawamura, T; Sasaki, K; Tanizawa, Y; Terashima, M; Tokunaga, M, 2012) |
| "Gluteal recurrence of the original gastric cancer was suggested, and systemic chemotherapy consisting of S-1 at 100 mg/day (3 weeks on, 1 week off) and CDDP (day 8) was started." | 1.37 | Good response chemotherapy for late-recurring gastric cancer in the gluteals, with peritoneal and retroperitoneal dissemination. ( Deguchi, R; Iwata, Y; Mine, T; Numata, M; Ogasawara, F; Ohtani, Y; Sakuma, T; Sato, S; Takashimizu, S, 2011) |
| "An endoscopic study revealed gastric cancer in the lesser curvature wall of the middle body of the stomach, and signet-ring cell carcinoma was confirmed histologically." | 1.35 | Systemic chemotherapy of TS-1 and cisplatin for gastric signet-ring cell carcinoma presenting as cardiac tamponade. ( Baba, E; Fujihara, M; Kaji, Y; Kusaba, H; Nagashima, R; Nakano, S, 2008) |
| " We therefore reduced the dosage of TS-1 from 80 mg/body/day to 60 mg/body/day." | 1.34 | [A resected case of advanced gastric cancer after treatment with low-dosage TS-1]. ( Aoyagi, K; Imaizumi, T; Koufuji, K; Matono, K; Miyagi, M; Ogata, Y; Shirouzu, K; Takeda, J; Yano, S, 2007) |
| "We report a case with gastric cancer and lung metastasis,who responded remarkably to combination chemotherapy using S-1 and weekly CDDP." | 1.34 | [A case of advanced gastric cancer with lung metastasis effectively treated by combination chemotherapy using S-1 and CDDP]. ( Akamatsu, M; Karimata, H; Nagahama, M; Nishimaki, T; Takaesu, H; Teruya, J, 2007) |
| "She was diagnosed as primary gastric cancer with peritoneal dissemination and received systemic chemotherapy after distal gastrectomy for a primary lesion." | 1.34 | [A case of breast metastasis of gastric cancer]. ( Cho, H; Hasegawa, S; Kobayashi, O; Osaragi, T; Sairenji, M; Tsuburaya, A; Yoshida, T; Yoshikawa, T, 2007) |
| " Furthermore, she was administered tegafur/uracil (400 mg/day) 5 days weekly for pharmacokinetic modulating chemotherapy (PMC)." | 1.33 | [A case of advanced gastric cancer with bone metastasis and severe DIC responding to hypertensive subselective chemotherapy with pharmacokinetic modulating chemotherapy]. ( Ishikawa, T; Kamimura, T; Mizuno, K; Ohta, H; Seki, K; Togashi, T; Watanabe, K; Yoshida, T, 2005) |
| "We report a patient with gastric cancer successfully treated with TS-1 and low-dose CDDP as neoadjuvant chemotherapy." | 1.33 | [A Case of advanced gastric cancer successfully treated with TS-1/low-dose CDDP as neoadjuvant chemotherapy]. ( Ebina, T; Kawasaki, H; Kobori, H; Sasaki, M; Seino, K; Shibata, S; Sugiyama, Y; Tanaka, M; Yamada, K, 2005) |
| "We report a 29-year-old woman with gastric cancer who developed Trousseau's syndrome, a malignancy-related thromboembolism, during chemotherapy." | 1.33 | Acute cerebral infarction during combination chemotherapy with s-1 and cisplatin for a young patient with a mucin-producing adenocarcinoma of the stomach. ( Asada, M; Chiba, T; Fukui, T; Nishio, A; Ohashi, S; Yazumi, S, 2006) |
| "The patient was diagnosed with type III gastric cancer by gastroendoscopy post-operatively, and TS-1/CDDP therapy was started on the 28th day after surgery." | 1.33 | [A case of perforated gastric cancer in which complete response was confirmed with resection following TS-1/CDDP combined chemotherapy after omentopexy]. ( Hagiwara, C; Hirama, K; Matsumoto, R; Ohguro, H; Sakamoto, Y, 2006) |
| "Paclitaxel was administered to 4 patients at a weekly dose of 80 mg/m2/day for three weeks followed by a one week interval." | 1.32 | [Treatment outcomes with paclitaxel for advanced gastric cancer patients previously treated with TS-1]. ( Chida, N; Imai, G; Ishibashi, J; Iwabuchi, M; Matsuda, Y; Mochida, A; Shiina, M; Suzuki, S; Suzuki, T; Tadokoro, K; Takahashi, H; Yamada, K; Yokoyama, H, 2003) |
| "Survival of patients with advanced gastric cancer with Krukenberg's tumor is poor." | 1.32 | [A case of type 4 gastric cancer, diagnosed after operation for Krukenberg's tumor, treated by TS-1 plus low-dose cisplatinum]. ( Akiba, Y; Aoki, D; Hibi, T; Ishii, H; Kato, S; Mukai, M; Naito, K; Takada, Y; Watanabe, C, 2003) |
| "An umbilical metastasis of gastric cancer is known as Sister Mary Joseph's nodule." | 1.32 | [A case of gastric cancer with umbilical metastasis that responded to TS-1 with low-dose cis-platinum]. ( Fukunaga, S; Hirakawa, K; Inoue, T; Ishikawa, T; Kato, Y; Nakata, B; Nishiguchi, Y; Ohira, M; Takashima, T; Yamagata, S; Yashiro, M, 2004) |
| "A 56-year-old gastric cancer patient with multiple lung metastases and dilated cardiomyopathy was treated by chemotherapy with TS-1." | 1.32 | [A case of gastric cancer complicated with multiple lung metastases responding to TS-1]. ( Ishiguro, S; Isobe, N; Iwabuchi, H; Kawabe, A; Yamamoto, T; Yamasaki, S, 2004) |
| "We report two elderly gastric cancer patients responding to chronomodulation chemotherapy (tegafur + cisplatin + Isovorin) based on circadian rhythms plus a new antitumor drug, S-1." | 1.31 | [Two elderly patients with advanced gastric cancer responding to chronomodulation chemotherapy with tegafur + cisplatin + isovorin followed by oral administration of S-1]. ( Kobayashi, A; Yamaguchi, M, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 34 (64.15) | 29.6817 |
| 2010's | 18 (33.96) | 24.3611 |
| 2020's | 1 (1.89) | 2.80 |
| Authors | Studies |
|---|---|
| Shoji, T | 1 |
| Takeshita, R | 1 |
| Saito, T | 1 |
| Aida, T | 1 |
| Sasou, S | 1 |
| Baba, T | 1 |
| Kawamitsu, K | 1 |
| Ooshiro, T | 1 |
| Nabekura, D | 1 |
| Kadoya, K | 1 |
| Sato, A | 1 |
| Kitahara, T | 1 |
| Takagi, R | 1 |
| Hiranuma, A | 1 |
| Urita, T | 1 |
| Yoshida, Y | 1 |
| Sato, Y | 1 |
| Tanaka, H | 1 |
| Nagashima, M | 1 |
| Okazumi, S | 1 |
| Kato, R | 1 |
| Nakachi, K | 1 |
| Konishi, M | 1 |
| Ikeda, M | 1 |
| Shimada, K | 1 |
| Okusaka, T | 1 |
| Saiura, A | 1 |
| Ishii, H | 2 |
| Sugiyama, M | 1 |
| Furuse, J | 1 |
| Sakamoto, H | 1 |
| Shimamura, T | 1 |
| Ohta, T | 1 |
| Onoe, A | 1 |
| Matsuura, D | 1 |
| Terui, T | 1 |
| Morikawa, H | 1 |
| Fujii, M | 2 |
| Ochiai, T | 1 |
| Shinkai, M | 1 |
| Imano, M | 1 |
| Chiba, Y | 1 |
| Iwama, M | 1 |
| Shiraisi, O | 1 |
| Yasuda, A | 1 |
| Tsubaki, M | 1 |
| Nishida, S | 1 |
| Kimura, Y | 1 |
| Yasuda, T | 1 |
| Xu, X | 1 |
| Zheng, G | 1 |
| Zhang, T | 1 |
| Zhao, Y | 1 |
| Zheng, Z | 1 |
| Tanizawa, Y | 1 |
| Bando, E | 1 |
| Kawamura, T | 1 |
| Tokunaga, M | 1 |
| Sasaki, K | 1 |
| Terashima, M | 1 |
| Ito, S | 1 |
| Nakamura, Y | 2 |
| Noumi, T | 1 |
| Sasaki, Y | 1 |
| Saito, M | 1 |
| Yano, K | 1 |
| Kamigaki, T | 1 |
| Goto, S | 1 |
| Yoshizawa, J | 1 |
| Shirozaki, T | 1 |
| Inoue, K | 1 |
| Maruyama, A | 1 |
| Karasawa, F | 1 |
| Nakayama, A | 1 |
| Takeuchi, N | 1 |
| Ito, N | 1 |
| Fujiwara, M | 1 |
| Toiyama, Y | 1 |
| Inoue, Y | 1 |
| Saigusa, S | 1 |
| Kawamura, M | 1 |
| Kawamoto, A | 1 |
| Okugawa, Y | 1 |
| Hiro, J | 1 |
| Tanaka, K | 1 |
| Mohri, Y | 1 |
| Kusunoki, M | 1 |
| Takeyama, H | 1 |
| Mizushima, T | 1 |
| Nakajima, K | 1 |
| Uemura, M | 1 |
| Haraguchi, N | 1 |
| Nishimura, J | 1 |
| Hata, T | 1 |
| Takemasa, I | 1 |
| Yamamoto, H | 1 |
| Doki, Y | 1 |
| Mori, M | 1 |
| Matsuoka, T | 1 |
| Hosaka, S | 1 |
| Inada, K | 1 |
| Kawamoto, S | 1 |
| Lee, SJ | 1 |
| Sohn, TS | 1 |
| Lee, J | 1 |
| Park, SH | 1 |
| Park, JO | 1 |
| Lim, DH | 1 |
| Park, YS | 1 |
| Lim, HY | 1 |
| Choi, MG | 1 |
| Lee, JH | 1 |
| Bae, JM | 1 |
| Kim, S | 1 |
| Kang, WK | 1 |
| Jeong, JH | 1 |
| Park, SR | 1 |
| Ahn, Y | 1 |
| Ryu, MH | 1 |
| Ryoo, BY | 1 |
| Kong, SY | 1 |
| Yook, JH | 1 |
| Yoo, MW | 1 |
| Kim, BS | 2 |
| Kang, YK | 1 |
| Yuza, K | 1 |
| Sakata, J | 1 |
| Soma, D | 1 |
| Ando, T | 1 |
| Hirose, Y | 1 |
| Ishikawa, H | 1 |
| Miura, K | 1 |
| Tatsuda, K | 1 |
| Ohashi, T | 1 |
| Takizawa, K | 1 |
| Nagahashi, M | 1 |
| Kameyama, H | 1 |
| Kobayashi, T | 1 |
| Kosugi, S | 1 |
| Wakai, T | 1 |
| Senoo, S | 1 |
| Mannami, T | 1 |
| Tamura, T | 1 |
| Fujiwara, N | 1 |
| Ikeda, G | 1 |
| Komoda, M | 1 |
| Ohtawa, Y | 1 |
| Fujimoto, Y | 1 |
| Sato, N | 1 |
| Kambara, T | 1 |
| Waku, T | 1 |
| Kenmotsu, M | 1 |
| Kurimoto, E | 1 |
| Okada, T | 1 |
| Harita, S | 1 |
| Sonobe, H | 1 |
| Qiu, MZ | 1 |
| Teng, KY | 1 |
| Ruan, DY | 1 |
| Li, YH | 1 |
| Chen, XQ | 1 |
| Pan, ZZ | 1 |
| He, YJ | 1 |
| Wan, DS | 1 |
| Xu, RH | 1 |
| Kumagai, K | 1 |
| Saikawa, Y | 2 |
| Fukuda, K | 1 |
| Ito, R | 1 |
| Igarashi, T | 1 |
| Tsuwano, S | 1 |
| Nakamura, R | 1 |
| Takahashi, T | 1 |
| Takeuchi, H | 1 |
| Kitagawa, Y | 1 |
| Sakuma, T | 1 |
| Deguchi, R | 1 |
| Takashimizu, S | 1 |
| Ogasawara, F | 1 |
| Numata, M | 1 |
| Ohtani, Y | 1 |
| Sato, S | 1 |
| Mine, T | 1 |
| Iwata, Y | 1 |
| Kayatani, H | 1 |
| Matsuo, K | 1 |
| Ueda, Y | 1 |
| Matsushita, M | 1 |
| Fujiwara, K | 1 |
| Yonei, T | 1 |
| Yamadori, I | 1 |
| Shigematsu, H | 1 |
| Andou, A | 1 |
| Sato, T | 2 |
| Arai, W | 2 |
| Hosoya, Y | 2 |
| Hyodo, M | 2 |
| Yokoyama, T | 2 |
| Saito, S | 2 |
| Kurasina, K | 1 |
| Aoki, T | 1 |
| Yasuda, Y | 2 |
| Nagai, H | 2 |
| Tamada, K | 1 |
| Baba, M | 1 |
| Higaki, N | 1 |
| Nishihara, M | 1 |
| Ishida, M | 1 |
| Kawasaki, H | 2 |
| Sasayama, Y | 1 |
| Suzuki, T | 1 |
| Iwabuchi, M | 1 |
| Matsuda, Y | 1 |
| Imai, G | 1 |
| Yokoyama, H | 1 |
| Mochida, A | 1 |
| Takahashi, H | 2 |
| Shiina, M | 1 |
| Yamada, K | 2 |
| Ishibashi, J | 1 |
| Suzuki, S | 1 |
| Chida, N | 1 |
| Tadokoro, K | 1 |
| Akiba, Y | 1 |
| Watanabe, C | 1 |
| Takada, Y | 1 |
| Naito, K | 1 |
| Aoki, D | 1 |
| Mukai, M | 1 |
| Kato, S | 1 |
| Hibi, T | 1 |
| Omatsu, T | 1 |
| Ichikawa, H | 1 |
| Kawahito, Y | 1 |
| Ashihara, E | 1 |
| Yamamoto, A | 1 |
| Kadoya, M | 1 |
| Takegami, T | 1 |
| Takanashi, Y | 1 |
| Naito, Y | 1 |
| Yoshida, N | 1 |
| Sugino, S | 1 |
| Yoshikawa, T | 2 |
| Wakabayashi, K | 2 |
| Hayashi, S | 2 |
| Masuda, H | 2 |
| Karube, H | 2 |
| Ookame, H | 1 |
| Aoki, H | 2 |
| Sakamoto, N | 2 |
| Takayama, T | 1 |
| Hirashima, Y | 1 |
| Shirasaka, T | 1 |
| Akesaka, K | 1 |
| Nakanishi, N | 1 |
| Ueda, N | 1 |
| Moritaka, T | 1 |
| Kitajima, T | 1 |
| Katsuta, T | 1 |
| Furuya, K | 1 |
| Nakayama, H | 1 |
| Aoki, N | 1 |
| Ogame, H | 1 |
| Hemmi, A | 1 |
| Takashima, T | 1 |
| Yamagata, S | 1 |
| Fukunaga, S | 1 |
| Inoue, T | 1 |
| Yashiro, M | 1 |
| Nakata, B | 1 |
| Nishiguchi, Y | 1 |
| Kato, Y | 1 |
| Ohira, M | 1 |
| Ishikawa, T | 2 |
| Hirakawa, K | 1 |
| Katase, K | 1 |
| Shimizu, Y | 1 |
| Kobayashi, Y | 1 |
| Hasumi, K | 1 |
| Akatsu, Y | 1 |
| Kubota, T | 1 |
| Yoshida, M | 1 |
| Furukawa, T | 1 |
| Otani, Y | 1 |
| Kumai, K | 1 |
| Kitajima, M | 1 |
| Ishiguro, S | 1 |
| Iwabuchi, H | 1 |
| Isobe, N | 1 |
| Kawabe, A | 1 |
| Yamasaki, S | 1 |
| Yamamoto, T | 1 |
| Mizuno, K | 1 |
| Togashi, T | 1 |
| Watanabe, K | 1 |
| Seki, K | 1 |
| Ohta, H | 1 |
| Yoshida, T | 2 |
| Kamimura, T | 1 |
| Kuriyama, H | 1 |
| Nonaka, T | 1 |
| Sawatari, T | 1 |
| Tsuboi, H | 1 |
| Akanuma, M | 1 |
| Hata, Y | 1 |
| Hiramatsu, K | 1 |
| Mizukami, Y | 1 |
| Momiyama, M | 1 |
| Suzuki, M | 1 |
| Niimi, K | 1 |
| Nagashima, T | 1 |
| Shibata, N | 1 |
| Eto, TA | 1 |
| Hotokezaka, M | 1 |
| Iwamura, T | 1 |
| Chijiiwa, K | 1 |
| Sakai, Y | 1 |
| Saotome, T | 1 |
| Fujimori, M | 1 |
| Shimizu, S | 1 |
| Inkyo, T | 1 |
| Yugeta, H | 1 |
| Ohbu, M | 1 |
| Koma, Y | 1 |
| Nagashima, F | 1 |
| Hayasaka, A | 1 |
| Fukuyama, Y | 1 |
| Tsuchiya, S | 1 |
| Tsuyuguchi, T | 1 |
| Saisho, H | 1 |
| Sugiyama, Y | 1 |
| Seino, K | 1 |
| Kobori, H | 1 |
| Ebina, T | 1 |
| Shibata, S | 1 |
| Sasaki, M | 1 |
| Tanaka, M | 1 |
| Kodama, T | 1 |
| Ishida, H | 1 |
| Okino, T | 1 |
| Okamoto, R | 1 |
| Hayashi, N | 1 |
| Mori, K | 1 |
| Noguchi, M | 1 |
| Ohashi, S | 1 |
| Yazumi, S | 1 |
| Nishio, A | 1 |
| Fukui, T | 1 |
| Asada, M | 1 |
| Chiba, T | 1 |
| Sakamoto, Y | 1 |
| Hirama, K | 1 |
| Hagiwara, C | 1 |
| Matsumoto, R | 1 |
| Ohguro, H | 1 |
| Kusakari, C | 1 |
| Soda, H | 1 |
| Yamaguchi, H | 1 |
| Kitazaki, T | 1 |
| Nakano, H | 1 |
| Matsubara, Y | 1 |
| Hayashi, T | 1 |
| Nagasaki, T | 1 |
| Nagayasu, T | 1 |
| Kohno, S | 1 |
| Matono, K | 1 |
| Ogata, Y | 1 |
| Koufuji, K | 1 |
| Aoyagi, K | 1 |
| Yano, S | 1 |
| Miyagi, M | 1 |
| Imaizumi, T | 1 |
| Takeda, J | 1 |
| Shirouzu, K | 1 |
| Karimata, H | 1 |
| Nagahama, M | 1 |
| Akamatsu, M | 1 |
| Teruya, J | 1 |
| Takaesu, H | 1 |
| Nishimaki, T | 1 |
| Hasegawa, S | 1 |
| Osaragi, T | 1 |
| Cho, H | 1 |
| Tsuburaya, A | 1 |
| Kobayashi, O | 1 |
| Sairenji, M | 1 |
| Kusaba, H | 1 |
| Fujihara, M | 1 |
| Nagashima, R | 1 |
| Kaji, Y | 1 |
| Baba, E | 1 |
| Nakano, S | 1 |
| Kobayashi, A | 1 |
| Yamaguchi, M | 1 |
| Michiwa, Y | 1 |
| Earashi, M | 1 |
| Kobayashi, H | 1 |
| Matsuki, N | 1 |
| Iwatani, Y | 1 |
| Shimada, Y | 1 |
| Ohshima, T | 1 |
| Kusunoki, N | 1 |
| Yamazaki, T | 1 |
| Miyazaki, N | 1 |
| Deguchi, Y | 1 |
| Nashimoto, A | 1 |
| Yabusaki, H | 1 |
| Tanaka, O | 1 |
| Sasaki, J | 1 |
| Touyama, H | 1 |
| Hokama, S | 1 |
| Hatano, T | 1 |
| Ogawa, Y | 1 |
1 trial available for tegafur and Signet Ring Cell Carcinoma
| Article | Year |
|---|---|
Phase II trial of neoadjuvant chemotherapy with intraperitoneal paclitaxel, S-1, and intravenous cisplatin and paclitaxel for stage IIIA or IIIB gastric cancer.
Topics: Adenocarcinoma; Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined | 2019 |
52 other studies available for tegafur and Signet Ring Cell Carcinoma
| Article | Year |
|---|---|
A case of primary ovarian signet-ring cell carcinoma treated with S-1/CDDP therapy.
Topics: Antimetabolites, Antineoplastic; Biomarkers, Tumor; Biopsy; Carcinoma, Signet Ring Cell; Drug Combin | 2020 |
[A Case of Advanced Gastric Cancer Responding Effectively to Neoadjuvant Chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; C | 2017 |
Feasibility study of postoperative adjuvant chemotherapy with S-1 in patients with biliary tract cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Biliary Tract Neoplasms; Carcinoma, Papillary; Carcino | 2018 |
Erythematous lesion with peripheral purpura on the face.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Chee | 2019 |
Is pathologic tumor regression grade after neo-adjuvant chemotherapy a promising prognostic indicator for patients with locally advanced gastric cancer? A cohort study evaluating tumor regression response.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol | 2019 |
Intramucosal gastric cancer with fifteen metastatic lymph nodes: report of a case.
Topics: Aged; Antimetabolites, Antineoplastic; Biopsy; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; | 2012 |
Acute aortic thrombosis during cisplatin based chemotherapy for gastric cancer.
Topics: Acute Disease; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Aortic Diseases; Aort | 2013 |
A patient with scirrhous stomach cancer treated with combination of hyperthermotherapy and 5-aminolevulinic acid (ALA).
Topics: Adenocarcinoma, Scirrhous; Adult; Aminolevulinic Acid; Antineoplastic Combined Chemotherapy Protocol | 2013 |
[A case of advanced signet ring cell carcinoma of the appendix that responded to S-1 and docetaxel].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Appendiceal Neoplasms; Carcinoma, Sign | 2013 |
C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Proto | 2013 |
Metachronous, colitis-associated rectal cancer that developed after sporadic adenocarcinoma in an adenoma in a patient with longstanding Crohn's disease: a case report.
Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cel | 2013 |
[A case of delayed subcutaneous metastases of gastric carcinoma effectively treated with S-1 plus cisplatin chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Drug Combina | 2013 |
Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 2014 |
Associations between CYP2A6 polymorphisms and outcomes of adjuvant S-1 chemotherapy in patients with curatively resected gastric cancer.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biomarker | 2017 |
[Signet-Ring Cell Carcinoma of the Ampulla of Vater--Report of a Case].
Topics: Ampulla of Vater; Antimetabolites, Antineoplastic; Carcinoma, Signet Ring Cell; Drug Combinations; D | 2015 |
[HER2-Positive Advanced Gastric Cancer with Disseminated Intravascular Coagulation and Diffuse Bone Marrow Carcinomatosis Successfully Treated with S-1/Trastuzumab Chemotherapy--A Case Report].
Topics: Aged; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Neoplasms; | 2015 |
[Impact of adjuvant chemotherapy duration on 3-year disease-free survival of colorectal carcinoma patients after radical resection].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Age Factors; Aged; Antineoplastic Combined Chemothe | 2009 |
Octreotide acetate successfully treated a bowel obstruction caused by peritoneally disseminated gastric cancer, thereby enabling the subsequent use of oral S-1 chemotherapy.
Topics: Adenocarcinoma; Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined | 2009 |
Good response chemotherapy for late-recurring gastric cancer in the gluteals, with peritoneal and retroperitoneal dissemination.
Topics: Antineoplastic Combined Chemotherapy Protocols; Buttocks; Carcinoma, Signet Ring Cell; Cisplatin; Dr | 2011 |
Pulmonary tumor thrombotic microangiopathy diagnosed antemortem and treated with combination chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Signet Ring Cell; Cisplati | 2012 |
[Every-other-day TS-1 administration for recurrent or non-curative advanced gastric carcinoma].
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Antimetabolites, Antineoplastic; Carcinoma, Signet Ring C | 2002 |
[A case of unresectable advanced gastric cancer with peritoneal dissemination responding to UET/low-dose CDDP combination chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; C | 2002 |
[Treatment outcomes with paclitaxel for advanced gastric cancer patients previously treated with TS-1].
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Proto | 2003 |
[A case of type 4 gastric cancer, diagnosed after operation for Krukenberg's tumor, treated by TS-1 plus low-dose cisplatinum].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; | 2003 |
[A case of advanced gastric cancer with bone metastases and DIC responding to oral administration of TS-1].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Bone Neoplasms; Carcinoma, Signet Ring | 2003 |
[Remarkable response of simultaneous advanced esophageal and gastric cancer to combined chemotherapy with weekday-on/Weekend-off TS-1 plus biweekly cisplatin].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Carcinoma, Squamo | 2003 |
[A case of type 4 gastric cancer with peritoneal dissemination successfully treated over 2 years by alternate-day administration of TS-1].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Carcinoma, Signet Ring Cell; Drug Administration Sc | 2004 |
[A case of carcinomatous lymphangitis of the lungs due to stomach cancer responding to TS-1].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Carcinoma, Signet Ring Cell; Drug Administration Sc | 2004 |
[A case of long survival with UFT and lentinan treatment in a patient with peritoneal metastasis of gastric carcinoma].
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryo | 2004 |
[A case of gastric cancer with umbilical metastasis that responded to TS-1 with low-dose cis-platinum].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplat | 2004 |
[Chemotherapy with combination of UFT and cisplatin against metastatic ovarian tumor originating from gastric cancer].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring | 2004 |
Clinical and pathological disappearance of peritoneal dissemination in a patient with advanced gastric cancer receiving chemotherapy with S-1 and low-dose cisplatin.
Topics: Ascites; Carcinoma, Signet Ring Cell; Cisplatin; Drug Combinations; Drug Therapy, Combination; Femal | 2004 |
[A case of gastric cancer complicated with multiple lung metastases responding to TS-1].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Carcinoma, Signet Ring Cell; Cardiomyopathy, | 2004 |
[A case of advanced gastric cancer with bone metastasis and severe DIC responding to hypertensive subselective chemotherapy with pharmacokinetic modulating chemotherapy].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Signet Ri | 2005 |
[A case of advanced gastric cancer with peritoneal dissemination effectively treated by combined chemotherapy of paclitaxel (TXL) and TS-1].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Drug Administration Sch | 2005 |
[Stage IV gastric cancer patient who underwent palliative gastrectomy showing complete response to induction therapy with methotrexate plus 5-fluorouracil and secondary treatment with oral TS-1].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Pr | 2005 |
[An unresectable advanced gastric cancer with Virchow's metastasis, carcinomatous ascites and rectal stenosis, effectively managed with combined chemotherapy of biweekly paclitaxel and TS-1].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined C | 2005 |
[A pilot study of TS-1+CDDP therapy for highly advanced stage IV gastric cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet | 2005 |
[A Case of advanced gastric cancer successfully treated with TS-1/low-dose CDDP as neoadjuvant chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; | 2005 |
[A case report of complete response by TS-1 and paclitaxel combination chemotherapy for advanced gastric cancer].
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Drug Administ | 2006 |
Acute cerebral infarction during combination chemotherapy with s-1 and cisplatin for a young patient with a mucin-producing adenocarcinoma of the stomach.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; C | 2006 |
[A case of perforated gastric cancer in which complete response was confirmed with resection following TS-1/CDDP combined chemotherapy after omentopexy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Drug Adminis | 2006 |
Mediastinal signet-ring cell carcinoma of unknown primary: long-term survival by treatment with S-1, a novel derivative of 5-fluorouracil.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Signet Ring Cell; Cisplatin | 2007 |
[A resected case of advanced gastric cancer after treatment with low-dosage TS-1].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; D | 2007 |
[A case of advanced gastric cancer with lung metastasis effectively treated by combination chemotherapy using S-1 and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Drug Adminis | 2007 |
[A case of breast metastasis of gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Signet Ring Cell; Cispl | 2007 |
Systemic chemotherapy of TS-1 and cisplatin for gastric signet-ring cell carcinoma presenting as cardiac tamponade.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cardiac Tamponade; Cisp | 2008 |
[Two elderly patients with advanced gastric cancer responding to chronomodulation chemotherapy with tegafur + cisplatin + isovorin followed by oral administration of S-1].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; | 2001 |
Cutaneous metastases from gastric adenocarcinoma treated with combination chemotherapy producing complete response with long survival.
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ri | 2001 |
[Postoperative chemotherapy with a novel oral anticancer drug composed of tegafur, gimeracil and oteracil potassium to curability C scirrhus type gastric cancer].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Carcinoma, Signet Ring Cell; Drug Administrat | 2001 |
[A case of remnant gastric cancer responding to neoadjuvant TS-1 therapy].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Carcinoma, Signet Ring Cell; Drug Admin | 2001 |
[Primary signet ring cell carcinoma of the urinary bladder: a case report].
Topics: Aged; Antineoplastic Agents; Carcinoma, Signet Ring Cell; Drug Combinations; Humans; Male; Tegafur; | 2001 |